Investhouse Ci Balanced Fund (A) - ICBA - Click a Unit Trust

Click a Unit Trust

JUMP TO: Fund objective Fund data Allocations List shares

0.26 / 0.18%

1.4377

NAV (ZAR) on 2024/09/12

NAV (ZAR) on 2024/09/11	1.4351
52 week high on 2024/09/02	1.4541
52 week low on 2023/10/27	1.2400
Total Expense Ratio on 2024/06/30	1.57
Total Expense Ratio (performance fee) on 2024/06/30	0

	NAV	Incl Dividends
1 month change	1.93%	1.93%
3 month change	2.38%	3.65%
6 month change	4.85%	6.16%
1 year change	11.15%	13.55%
5 year change	7.04%	9.34%
10 year change	0%	0%
Price data is updated once a day. Unit trust and ETF performances for periods greater than 12 months are annualised.

COMPARE INSTRUMENTS

Here is a list of JSE shares held in this Unit Trust. These tables reflect changes in holdings over two quarters, but do not show where a fund has completely sold a holding during the latest quarter.

Investhouse Ci Balanced Fund

Fund managed by Ci Collective Investments (RF) Prop Ltd.

Investhouse Ci Balanced Fund (A) - ICBA

Holdings	Jun 2024		Mar 2024		Unit change	Value change (R'000s)	% of Fund	manco	link	code
Holdings	# Units	Value (R'000s)	# Units	Value (R'000s)	Unit change	Value change (R'000s)	% of Fund	manco	link	code
AECI Ltd.	32,001	34,570.680	22,842	21,227.070	9,159	13,343.610	1.1800		AECI Ltd. - JSE:AFE	AFE
Afrimat Ltd.	18,657	13,207.290	56,403	32,617.850	-37,746	-19,410.560	0.4508		Afrimat Ltd. - JSE:AFT	AFT
Anglo American plc	667	3,845.260	667	3,102.620	0	742.640	0.1313		Anglo American plc - JSE:AGL	AGL
Anglo American Platinum Ltd.	931	5,602.010	4,623	35,527.290	-3,692	-29,925.280	0.1912		Anglo American Platinum Ltd. - JSE:AMS	AMS
Aspen Pharmacare Holdings Ltd.	1,865	4,351.230	1,865	4,091.440	0	259.790	0.1485		Aspen Pharmacare Holdings Ltd. - JSE:APN	APN
Total

The free version only lists 5 shares. Subscribe to see the full list.

SUBSCRIBE NOW

The objective of this multi asset portfolio is to provide investors with moderate capital growth. The portfolio aims to generate a return of CPI for all urban areas + 5% per annum over any rolling 5 year period and is aimed at the high risk investor as it is limited to a maximum of 75% exposure to equities . The portfolio adheres to the guidelines set by Regulation 28.